Now Offering Monoclonal Antibody Therapy, a Breakthrough COVID-19 Treatment Under Emergency Use Authorization by the FDA

By jsmith | January 29, 2021 | Comments Off on Now Offering Monoclonal Antibody Therapy, a Breakthrough COVID-19 Treatment Under Emergency Use Authorization by the FDA

Tulsa ER & Hospital now offers monoclonal antibody therapy as an alternative COVID-19 treatment option for those who meet the criteria mentioned below. The infusion therapies offered, including Eli Lilly’s bamlanivimab, and the combination of casirivimab and imdevimab, are under Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Admisinstration (FDA). Casirivimab and…

Read More